SUVZ.US Suvanza Pharma LLC
- Market cap
- -
- P/E
- -
- P/B
- 0.35x
- ROE
- -254.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2003.
Is SUVZ.US undervalued?
Graham numberThe Graham number of Suvanza Pharma LLC cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Suvanza Pharma LLC fundamental analysis
No fundamental analysis for Suvanza Pharma LLC yet.
Suvanza Pharma LLC stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Suvanza Pharma LLC
Suvanza Pharma, LLC operates as an early-stage biotechnology corporation and engages in the development of the skin drug delivery system, RapiDerm for dermatologic diseases. Suvanza Pharma, LLC was formerly known as Hamilton PNG and changed its name to Suvanza Pharma, LLC in March 2010. The company was founded in 2004 and is based in Miami Beach, Florida.
Full company profileSuvanza Pharma LLC financial statements
2003 annualized: Fiscal year 2003 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2003, the balance sheet is the latest quarter. Figures change when the annual report is published.
Suvanza Pharma LLC annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2000 | 2001 | 2002 | 2003 Anlz |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 1.00K | 51.0K | 0.00 | 28.0K |
| Gross Profit | 1.00K | 51.0K | -1.16M | -868K |
| Operating Income | -10.4M | -21.9M | -17.1M | -10.7M |
| Net Income | -9.47M | -20.9M | -16.8M | -10.7M |
| Balance Sheet | ||||
| Total Assets | 20.9M | 11.3M | 8.73M | 6.21M |
| Total Liabilities | 3.17M | 1.38M | 1.86M | 2.02M |
| Shareholders' Equity | 17.7M | 9.93M | 6.86M | 4.19M |
| Cash & Short-term Investments | 10.1M | 5.84M | 2.59M | 609K |
| Cash Flow | ||||
| Operating Cash Flow | -7.93M | -12.9M | -12.4M | -7.87M |
| Capital Expenditure | 2.47M | 865K | 349K | 20.0K |
| Ratios | ||||
| ROE | -53.5% | -210.1% | -245.3% | -254.9% |
| ROA | -45.4% | -184.5% | -192.9% | -172.1% |
| Net Profit Margin | -946,800.0% | -40,905.9% | - | -38,157.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Suvanza Pharma LLC dividends
Suvanza Pharma LLC has not paid dividends in the last 3 fiscal years.
Last stock split: 1:100 on Mar 19, 2010.
Who owns Suvanza Pharma LLC
Ownership data of Suvanza Pharma LLC is not available yet.
Suvanza Pharma LLC company profile
- Company name
- Suvanza Pharma LLC
- Ticker
- SUVZ.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Biotechnology
- Fiscal year end
- December
- Address
- 5401 Collins Avenue, Miami Beach, FL, United States, 33140
- Phone
- 866-633-9546
- Website
- suvanza.com
About Suvanza Pharma LLC
Suvanza Pharma, LLC operates as an early-stage biotechnology corporation and engages in the development of the skin drug delivery system, RapiDerm for dermatologic diseases. Suvanza Pharma, LLC was formerly known as Hamilton PNG and changed its name to Suvanza Pharma, LLC in March 2010. The company was founded in 2004 and is based in Miami Beach, Florida.
Suvanza Pharma LLC management
4- Dr. Nardo Zaias M.D.Interim CEO, President & Director · born 1932
- Dr. Manuel Zaiac Dr Juris, CPAInterim Chief Financial Officer
- Ms. Magaly FastTreasurer & Director
- Ed IaconisInterim Secretary